Back
Bionano Genomics, Inc. 10K Form
Sell
34
BNGO
Bionano Genomics, Inc.
Last Price:
$1.19
Seasonality Move:
-17.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNGO News And Ratings
See the #1 stock for the next 7 days that we like better than BNGO
BNGO Financial Statistics
Sales & Book Value
| Annual Sales: | $28.5M |
|---|---|
| Cash Flow: | $-4.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.14 |
| Price / Book: | 0.3 |
Profitability
| EPS (TTM): | -5.47560 |
|---|---|
| Net Income (TTM): | $-26.4M |
| Gross Margin: | $6.3M |
| Return on Equity: | -59.14% |
| Return on Assets: | -34.39% |
Bionano Genomics, Inc. Earnings Forecast
Key Bionano Genomics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for BNGO is 21.95%.
-
The Selling, General & Administrative Expenses for BNGO have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 39.90% of Revenue.
-
The Net Earning history of BNGO is -92.59% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 4 years.
Bionano Genomics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BNGO |
| CUSIP: | 09075F |
| Website: | bionano.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 1.98 |
| Quick Ratio: | 1.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNGO Technical Analysis vs Fundamental Analysis
Sell
34
Bionano Genomics, Inc. (BNGO)
is a Sell
Is Bionano Genomics, Inc. a Buy or a Sell?
-
Bionano Genomics, Inc. stock is rated a SellThe current Bionano Genomics, Inc. [BNGO] share price is $1.20. The Score for BNGO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.